{"id":14008,"date":"2026-02-20T11:12:57","date_gmt":"2026-02-20T11:12:57","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/14008\/"},"modified":"2026-02-20T11:12:57","modified_gmt":"2026-02-20T11:12:57","slug":"novartis-to-exit-indian-unit-in-159-million-deal-2","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/14008\/","title":{"rendered":"Novartis to exit Indian unit in $159 million deal"},"content":{"rendered":"\n<p class=\"yf-vbsvxt\">Feb 20 (Reuters) &#8211; Swiss drugmaker Novartis said on Friday \u200cit would sell its \u200centire 70.68% stake in its listed \u200bIndian unit for 14.46 billion rupees ($159 million).<\/p>\n<p class=\"yf-vbsvxt\">The stake will be acquired by a \u200cconsortium of \u2060WaveRise Investments, ChrysCapital and Two Infinity Partners.<\/p>\n<p class=\"yf-vbsvxt\">The companies \u2060have also made an offer to purchase an \u200badditional 26% \u200bstake from \u200bNovartis India&#8217;s \u200cpublic shareholders, under takeover regulations that mandate such an exercise on purchase of a shareholding of over 25%.<\/p>\n<p class=\"yf-vbsvxt\">The consortium \u200cwill offer Novartis \u200bIndia&#8217;s public shareholders \u200b860.64 \u200brupees per share, \u200can exchange filing showed, \u200brepresenting \u200ba 3.6% premium to its closing price on Thursday.<\/p>\n<p class=\"yf-vbsvxt\">($1 = \u200b91.0290 \u200cIndian rupees)<\/p>\n<p class=\"yf-vbsvxt\">(Reporting by Nandan \u200bMandayam in Bengaluru; Editing by \u200bSonia Cheema)<\/p>\n","protected":false},"excerpt":{"rendered":"Feb 20 (Reuters) &#8211; Swiss drugmaker Novartis said on Friday \u200cit would sell its \u200centire 70.68% stake in&hellip;\n","protected":false},"author":2,"featured_media":14009,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[127],"tags":[9992,10139,10140,206,10141,10047,9970],"class_list":{"0":"post-14008","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-novartis","8":"tag-chryscapital","9":"tag-indian-rupees","10":"tag-indian-unit","11":"tag-novartis","12":"tag-public-shareholders","13":"tag-takeover-regulations","14":"tag-two-infinity-partners"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/14008","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=14008"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/14008\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/14009"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=14008"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=14008"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=14008"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}